-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

652A.O3.6 652. Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Precursor States: MGUS and Smoldering Myeloma

Symposia: Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, adult, Translational Research, Clinical Practice (Health Services and Quality), epidemiology, Clinical Research, Plasma Cell Disorders, bioinformatics, Diseases, indolent lymphoma, immunology, real-world evidence, Lymphoid Malignancies, computational biology, registries, Biological Processes, Technology and Procedures, Study Population, Human, omics technologies
Saturday, December 10, 2022: 9:30 AM-11:00 AM
R02-R05 (Ernest N. Morial Convention Center)
Moderators:
Noa Biran, MD, Mount Sinai Hospital and Mary L Kwok, MD, Fred Hutch Cancer Center
Disclosures:
No relevant conflicts of interest to declare.
9:30 AM

Thorvardur Jon Love, MD, PhD1,2*, Sæmundur Rögnvaldsson, MD3*, Sigrun Thorsteinsdottir, MD, PhD1,4, Thor Aspelund, PhD1*, Elin Ruth Reed1*, Brynjar Vidarsson, MD2, Pall Torfi Onundarson, MD2, Bjarni Agnar Agnarsson, MD5*, Margret Sigurdardottir, MD2*, Ingunn Thorsteinsdottir, MD, PhD2*, Signy Vala Sveinsdottir, MD PhD5*, Isleifur Olafsson, MD, PhD5*, Fridbjorn Sigurdsson, MD5*, Asdis Rosa Thordardottir1*, Elias Eythorsson, MD, PhD5*, Asbjorn Jonsson, MD6*, Runolfur Palsson, MD1,5*, Olafur Skuli Indridason, MD, MHS1,5*, Gauti Gislason1*, Andri Olafsson1*, Jon Kristinn Sigurdsson1*, Ingigerdur Solveig Sverrisdottir, MD, BSc1,7*, Hlif Steingrimsdottir, MD5*, Thorir Einarsson Long, MD, PhD1,8*, Malin Hultcrantz, MD, PhD9, Brian G.M. Durie, MD10, Stephen Harding, PhD11, Ola Landgren, MD12 and Sigurdur Y Kristinsson, MD, PhD1,2

1Faculty of Medicine, University of Iceland, Reykjavik, Iceland
2Landspitali University Hospital, Reykjavik, Iceland
3Faculty of Medicine, University of Iceland, Reykjavík, Iceland
4Department of Hematology, Rigshospitalet, København, Copenhagen, Denmark
5Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
6Akureyri Hospital, Akureyri, Iceland
7Sahlgrenska University Hospital, Gothenburg, Sweden
8Skåne University Hospital, Lund, Sweden
9Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
10Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
11The Binding Site Inc., Birmingham, United Kingdom
12Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

9:45 AM

David F. Moreno, MD1*, Cristina Jiménez, PhD2*, Fernando Escalante Barrigón, MD3*, Elham Askari, MD4*, Mario Arnao, MD5*, Ángela Heredia, MD6*, Magdalena Alcalá, MD7*, Arancha Bermúdez, MD8*, Ana Saus Carreres9*, Maria Casanova, MD10*, Luis Palomera, MD, PhD11*, Cristina Motllo12*, Ricarda Belen Garcia Sanchez13*, Ramon Garcia-Sanz2 and Carlos Fernández De Larrea, MD, PhD1*

1Department of Hematology, IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain
2Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain
3Complejo Asistencial Universitario de León, León, Spain
4Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
5Department of Hematology, Hospital La Fe, Valencia, Spain
6Department of Hematology, Hospital Virgen de la Arrrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
7Department of Hematology, Hospital Universitario Carlos Haya, Málaga, Spain
8Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
9Department of Hematology, Hospital Clínico Universitario, Valencia, Spain
10Hospital Costa del Sol Marbella, Marbella, Spain
11Hospital Clínico U. "Lozano Blesa". Instituto Investigación Sanitaria Aragón, Zaragoza, Spain
12Hospital Althaia, Xarxa Assistencial de Manresa, Manresa, Spain
13Complejo Hospitalario de Especialidades Virgen de La Victoria, Málaga, Spain

10:00 AM

Robert Palmason1,2,3*, Elias Eythorsson, MD, PhD1*, Sæmundur Rögnvaldsson, MD1,4*, Sigrun Thorsteinsdottir, MD, PhD3,5, Sara Ekberg, PhD6*, Michael Crowther, PhD6*, Elin Ruth Reed3*, Jon Þórir Oskarsson, MSc7*, Gudrun Asta Sigurdardottir3*, Thor Aspelund, PhD3*, Brynjar Vidarsson, MD1, Pall Torfi Onundarson, MD1, Bjarni Agnar Agnarsson, MD1*, Margret Sigurdardottir, MD1*, Ingunn Thorsteinsdottir, MD, PhD1*, Signy Vala Sveinsdottir, MD PhD1*, Isleifur Olafsson, MD, PhD1*, Asdis Rosa Thordardottir3*, Asbjorn Jonsson, MD8*, Olafur Skuli Indridason, MD, MHS1*, Gauti Gislason3*, Andri Olafsson3*, Jon Kristinn Sigurdsson3*, Hlif Steingrimsdottir, MD1*, Thorir Einarsson Long, MD, PhD2,9*, Malin Hultcrantz, MD, PhD10, Brian G.M. Durie, MD11, Stephen Harding, PhD12, Ola Landgren, MD13, Runolfur Palsson, MD1*, Thorvardur Jon Love, MD, PhD3* and Sigurdur Y Kristinsson, MD, PhD1,3

1Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
2Skåne University Hospital, Lund, Sweden
3Faculty of Medicine, University of Iceland, Reykjavik, Iceland
4Faculty of Medicine, University of Iceland, Reykjavík, Iceland
5Department of Hematology, Rigshospitalet, København, Copenhagen, Denmark
6Red Door Analytics AB, Stockholm, Sweden
7Faculty of Medicine, University of Iceland, Reykjavik, Reykjavik, Iceland
8Akureyri Hospital, Akureyri, Iceland
9Faculty of Medicine, University of Iceland, Reykjavik, AL, Iceland
10Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
11Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
12The Binding Site Inc., Birmingham, United Kingdom
13Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

10:15 AM

Fumou Sun1*, Jun Ying2*, Yan Cheng1*, David Mery1*, Visanu Wanchai1,3*, Eric R. Siegel2*, Hongwei Xu1*, Dongzheng Gai1*, Jiahao Xu4*, Timothy Cody Ashby3*, Clyde Bailey5*, Samer Al Hadidi, MD, MSc1, Carolina Schinke1, Sharmilan Thanendrarajan, MD1, Maurizio Zangari, MD1, Frits van Rhee5, Siegfried Janz6, Guido Tricot1, John D Shaughnessy, Jr1* and Fenghuang Zhan, MD, PhD1

1Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
2Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR
3Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR
4The Baptist Preparatory School, Little Rock, AR
5Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
6Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

10:30 AM

Elias Eythorsson, MD, PhD1*, Sæmundur Rögnvaldsson, MD1,2*, Sigrún Thorsteinsdóttir, MD, PhD3,4, Elin Ruth Reed3*, Gudrún Ásta Sigurdardóttir3*, Brynjar Vidarsson, MD1, Páll Torfi Onundarson, MD1, Bjarni Agnarsson, MD1*, Margrét Sigurdardóttir, MD1*, Ísleifur Ólafsson, MD, PhD1*, Ingunn Þorsteinsdóttir, MD5*, Signy Vala Sveinsdottir, MD1*, Fridbjorn Sigurdsson, MD6*, Ásdis Rósa Thórdardottir3*, Runolfur Palsson, MD1,3*, Olafur Indridason, MD, MHS2,7*, Thorir Einarsson Long, MD, PhD8,9*, Asbjorn Jonsson, MD6*, Gauti Kjartan Gislason, MSc3*, Andri Olafsson3*, Jon Kristinn Sigurdsson3*, Hlif Steingrimsdottir, MD1*, Malin Hultcrantz, MD, PhD10, Brian G.M. Durie, MD11, Stephen Harding, PhD12, Ola Landgren, MD13, Thor Aspelund, PhD3*, Thorvardur Jon Love, MD, PhD3* and Sigurdur Y Kristinsson, MD, PhD1,3

1Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
2Faculty of Medicine, University of Iceland, Reykjavík, Iceland
3Faculty of Medicine, University of Iceland, Reykjavik, Iceland
4Department of Hematology, Rigshospitalet, Copenhagen, Copenhagen, Denmark
5Landspitali - The National University Hospital of Iceland, Reykjavík, Iceland
6Akureyri Hospital, Akureyri, Iceland
7Landspítali-The National University Hospital of Iceland, Reykjavik, ISL
8Faculty of Medicine, University of Iceland, Reykjavik, AL, Iceland
9Skåne University Hospital, Lund, Sweden
10Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
11Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
12The Binding Site Inc., Birmingham, United Kingdom
13Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

10:45 AM

Romanos Sklavenitis-Pistofidis, MD1,2,3, Michelle P. Aranha, PhD1,2,3*, Nicholas J. Haradhvala, PhD2*, Shohreh Varmeh, PhD3*, Daniel Heilpern-Mallory, BS2,3*, Ting Wu, MS2*, Nang Kham Su, MSc3*, Elizabeth D. Lightbody, PhD1,2,3, François Aguet, PhD2*, Oksana Zavidij, PhD3*, Sabrin Tahri, MD1,2,3*, Tarek H. Mouhieddine, MD1,2,3, Gad Getz, PhD1,2,4* and Irene Ghobrial, MD1,2,3

1Department of Medicine, Harvard Medical School, Boston, MA
2Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Department of Pathology, Massachusetts General Hospital Cancer Center, Boston, MA

*signifies non-member of ASH